Profits of Large Pharmaceutical Companies Compared to Other Large Public Companies

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, MARCH 3, 2020

Media advisory: The full study and related articles are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.0442?guestAccessKey=491e2e58-ebda-412f-a1d0-962b379cd679&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030320

 

What The Study Did: Data from annual financial reports were used to compare the profitability of 35 large pharmaceutical companies with 357 companies in the S&P 500 Index from 2000 to 2018. This study is part of a theme issue from JAMA on drug pricing.

Authors: Fred D. Ledley, of Bentley University in Waltham, Massachusetts, is the corresponding author.

 

(doi:10.1001/jama.2020.0442)

Editor’s Note: The article includes funding/support disclosures. Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.